GHK-Cu Topical Peptide: Mechanism, Evidence & Use

GHK-Cu (copper tripeptide-1) is a naturally occurring copper-binding tripeptide — glycyl-L-histidyl-L-lysine complexed with copper(II) — that, when delivered topically, signals collagen synthesis, antioxidant defence, and tissue-repair pathways in the skin, and at 340 Da it is small enough to cross the stratum corneum better than most cosmetic peptides.

This guide covers the GHK-Cu topical mechanism, the human and in-vitro evidence, how topical compares to injectable delivery for this specific molecule, and what to look for in a GHK-Cu serum or cream. For the full pharmacology and physical properties, see the GHK-Cu monograph.

What is GHK-Cu and how does the topical peptide work?

GHK-Cu is a tripeptide first isolated from human plasma by Loren Pickart in 1973. The free peptide GHK has an extremely high affinity for copper(II) ions and spontaneously forms the GHK-Cu complex, which is the biologically active species. Its molecular weight is 340 Da (GHK alone is ~340.4 g/mol; the copper complex ~403 g/mol depending on counter-ion), and plasma GHK declines from ~200 ng/mL at age 20 to ~80 ng/mL by age 60 (Pickart & Margolina, 2018, PMID: 29987172).

Applied topically, GHK-Cu acts through several mechanisms researchers have characterised:

• Collagen and matrix synthesis — upregulates collagen types I, III, and VI, plus elastin, fibronectin, and decorin in dermal fibroblasts at nanomolar concentrations.
• Copper delivery — copper is a cofactor for lysyl oxidase (collagen cross-linking) and superoxide dismutase (antioxidant defence); GHK is the carrier.
• Gene modulation — GHK has been reported to shift expression of a large set of human genes toward a "younger," regenerative profile (Pickart, Vasquez-Soltero & Margolina, 2012, PMID: 22592076).
• Antioxidant and anti-inflammatory signalling — raises SOD activity and dampens inflammatory mediators in wound models.

Because copper is central to its action, GHK-Cu is classed as a carrier peptide rather than a pure signal peptide. The term itself is defined in our GHK-Cu glossary entry and copper peptide glossary entry.

What does research show about GHK-Cu topical for skin?

Human and ex-vivo studies report measurable skin improvements. A GHK-Cu facial cream improved skin density and thickness, reduced fine lines and wrinkles, and improved clarity, outperforming vitamin-C and retinoic-acid comparators on several endpoints in Pickart's comparative work (Pickart & Margolina, 2018, PMID: 29987172). In wound-healing models, GHK-Cu accelerated closure and upregulated VEGF-driven angiogenesis. Endpoints researchers typically measure:

• Wrinkle depth and volume by profilometry
• Skin density and thickness by ultrasound
• Barrier function by transepidermal water loss
• Collagen markers by immunostaining or qPCR

Key research on GHK-Cu

Three strands of published work anchor the topical GHK-Cu evidence base. First, the gene-regulation work: GHK was reported to reset the expression of a large set of human genes toward a more youthful, regenerative profile, including upregulation of DNA-repair and antioxidant genes (Pickart, Vasquez-Soltero & Margolina, 2012, PMID: 22592076). Second, the comparative cosmetic work in which a GHK-Cu cream improved skin density, thickness, clarity, and fine-line depth, outperforming vitamin-C and retinoic-acid comparators on several endpoints (Pickart & Margolina, 2018, PMID: 29987172). Third, the wound-healing and tissue-repair models, where GHK-Cu accelerated closure and induced VEGF-driven angiogenesis — the same angiogenic pathway summarised in our VEGF glossary entry.

Pickart & Margolina, 2018 (PMID: 29987172): GHK-Cu stimulates collagen types I, III, and VI and improves multiple skin-aging endpoints in topical application, with plasma GHK declining roughly 60% between ages 20 and 60.

Taken together, these studies explain why GHK-Cu is treated as the reference topical peptide: a defined mechanism (copper delivery + collagen and gene signalling), a favourable 340 Da molecular weight, and human cosmetic endpoints — not just in-vitro signals.

GHK-Cu peptide topical vs injection: which delivery?

For GHK-Cu specifically, topical delivery is the more evidence-backed route for skin endpoints because the target tissue is the skin, and at 340 Da the molecule absorbs reasonably well. Injectable/subcutaneous GHK-Cu is studied for systemic and wound contexts but is not better for cosmetic skin outcomes. We compare absorption, bioavailability, and use-cases fully in topical vs injectable peptides.

GHK-Cu topical serum vs cream: formulation factors

Whether in a serum or a cream, the variables that govern a GHK-Cu topical's performance are concentration (studies commonly use ~0.05–2%), pH (GHK-Cu is most stable in a mildly acidic to neutral range), and compatibility — direct L-ascorbic acid and strong exfoliating acids in the same layer can destabilise the copper complex. Serums tend to use penetration enhancers; creams provide occlusion that can aid hydration-driven uptake. Verification (≥98% HPLC purity, batch COA) matters more than serum-versus-cream format.

GHK-Cu topical for hair

Copper peptides including GHK-Cu are studied for follicular signalling — copper inhibits 5-alpha-reductase and copper-peptide complexes have prolonged anagen in follicle models. The scalp evidence is covered alongside delivery considerations in topical peptides for hair growth.

GHK-Cu physical properties

GHK-Cu's small size and well-defined chemistry are central to why it became the lead topical peptide. Researchers anchor on these figures:

At 340 Da the peptide sits comfortably below the ~500 Da stratum-corneum threshold (Bos & Meinardi, 2000, PMID: 11168751), which is the single most important reason topical GHK-Cu has measurable skin effects where larger peptides struggle.

What are the benefits and before-and-after expectations?

The benefits documented in GHK-Cu research are improvements in skin density, firmness, fine-line depth, clarity, and barrier function, and these changes typically emerge over weeks rather than days because they reflect collagen remodelling. In cosmetic studies, density and wrinkle endpoints are commonly reported over 8–12 weeks of consistent application (Pickart & Margolina, 2018, PMID: 29987172). "Before and after" expectations for topical GHK-Cu should therefore be framed on that timescale and as gradual texture and density improvement, not overnight change. Because GHK-Cu also upregulates VEGF-driven angiogenesis, wound-repair and post-procedure recovery are additional research contexts.

How does GHK-Cu compare to other copper peptides?

GHK-Cu is the benchmark copper peptide, but it is not the only one — AHK-Cu (an alanine-histidine-lysine copper complex) and other copper-binding sequences are also studied, generally with far less human data. What distinguishes GHK-Cu is its origin as a native human plasma tripeptide, its exceptionally well-characterised gene-modulation profile (Pickart, Vasquez-Soltero & Margolina, 2012, PMID: 22592076), and its favourable 340 Da weight. The broader category and the distinction from GHK-Cu specifically are defined in the copper peptide glossary entry.

GHK-Cu topical side effects and safety

Topical GHK-Cu is generally well tolerated in published cosmetic research, with the most commonly reported effects being mild, transient redness or irritation at the application site. The copper complex can be destabilised — and its tolerability altered — when applied in the same layer as strong acids such as direct L-ascorbic acid, so spacing those actives is common practice. GHK-Cu supplied by Aevitas is a Research Use Only material, not an approved cosmetic or drug, and pregnancy or clinical-use questions are matters for a qualified clinician rather than blanket guidance.

Aevitas GHK-Cu — Research Grade

Aevitas supplies GHK-Cu as a lyophilized powder at ≥98% HPLC purity, independently third-party verified, with a certificate of analysis in every batch. For researchers formulating or characterising a topical copper-peptide system, this is the reference material.

[Read the full GHK-Cu monograph →](/peptides/ghk-cu) · [Order GHK-Cu (50 mg) →](/product/ghk-cu-50mg) · View COA Library →

Frequently Asked Questions

What is GHK-Cu topical peptide good for? In published research, topical GHK-Cu is studied for collagen synthesis, skin density, wrinkle reduction, antioxidant defence, and wound repair. It is the most-characterised copper carrier peptide for skin endpoints.

Does GHK-Cu peptide work topically or only by injection? For skin endpoints, topical GHK-Cu has direct human evidence and absorbs reasonably well at 340 Da. Injection is studied for systemic and wound contexts but offers no advantage for cosmetic skin outcomes.

What are GHK-Cu topical side effects? Reported effects are generally mild and limited to transient application-site irritation; the copper complex can also be destabilised when layered with strong acids such as direct vitamin C.

What concentration of GHK-Cu is used in topical research? Studies commonly report concentrations in the ~0.05–2% range, with formulation pH and penetration enhancers strongly influencing the delivered dose.

Is topical GHK-Cu the same as a copper peptide? GHK-Cu is the best-known copper peptide, but "copper peptide" is a broader category. See the copper peptide glossary entry for the distinction.

---

Research Use Only · Not for human consumption · Not for veterinary use · None of the information on this page constitutes medical advice.

Related: GHK-Cu monograph · Topical peptides pillar · Topical vs injectable peptides